Loading...

The use of natalizumab for multiple sclerosis

Natalizumab is a monoclonal antibody that acts as an α4 integrin antagonist to prevent leukocyte trafficking into the central nervous system. It is US Food and Drug Administration (FDA) approved for the treatment of relapsing–remitting multiple sclerosis (RRMS). Natalizumab demonstrated high efficac...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychiatr Dis Treat
Main Authors: Brandstadter, Rachel, Katz Sand, Ilana
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5499927/
https://ncbi.nlm.nih.gov/pubmed/28721050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S114636
Tags: Add Tag
No Tags, Be the first to tag this record!